With eye diseases on the rise, the global Ophthalmic Drugs market is set for significant growth, increasing from USD 39,636.6 million in 2025 to USD 72,457.25 million by 2033. This 9.00% CAGR signals major advancements in treatments for glaucoma, dry eye, and other conditions. What’s driving this surge? Which innovations are shaping the industry? Join us as we explore the trends, key players, and the future of eye care.